Clinical criteria and biochemical markers for the detection of systolic dysfunction
Authors:
- John C. BurnettJBJohn C. Burnett
- Edmund A. BermudezEBEdmund A. Bermudez
- Michihisa JougasakiMJMichihisa Jougasaki
- Kent R. BaileyKBKent R. Bailey
- Margaret M. RedfieldMRMargaret M. Redfield
- 1 September 2000
- journal article
- research article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 6 (3) , 194-200
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- Sex and Test Verification BiasCirculation, 1997
- Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular HypertrophyHypertension, 1996
- Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunctionThe American Journal of Cardiology, 1996
- Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods.Heart, 1994
- Clinical utility of transthoracic two-dimensional and Doppler echocardiographyJACC, 1994
- Plasma concentrations of brain natriuretic peptide: will this new test reduce the need for cardiac investigations?Heart, 1993
- Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarctionThe Lancet, 1993
- Value of normal electrocardiographic findings in predicting resting left ventricular function in patients with chest pain and suspected coronary artery diseaseThe American Journal of Medicine, 1989
- Determination of left ventricular ejection fraction by visual estimation during real-time two-dimensional echocardiographyAmerican Heart Journal, 1982